Ocular Penetration of Topical Tacrolimus Eye Drops

Ocular Penetration of Topical Tacrolimus Clinical Trial

Status Recruiting

Clinical Trial Summary

Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops.

Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Ocular Penetration of Topical Tacrolimus

• NCT number: NCT02794610
• Study type: Interventional
• Source: The Eye Center and The Eye Foundation for Research in Ophthalmology
• Contact: Ssmir S Shoughy, MD
• Phone: +966 11 464 9614
• Email: samir.shawki@hotmail.com
• Status: Recruiting
• Phase: N/A
• Start date: May 2016
• Completion date: July 2016